| Notifications | Knee Orthoses | 05.00.47r | 3/8/2024 10:00 AM | 4/8/2024 | | | 3/8/2024 | General Description, Guidelines, or Informational Update | | |
| Notifications | Ambulatory Electrocardiography (AECG) Monitoring and Mobile Cardiac Outpatient Telemetry (MCOT) Monitoring | 07.02.21p | 3/22/2024 11:00 AM | 6/24/2024 | | | 3/22/2024 | Medical Coding | | |
| New Policies | Velmanase alfa (Lamzede) | 08.02.04 | | 3/11/2024 | | | 3/11/2024 | This is a New Policy. | | |
| Updated Policies | Dofetilide (Tikosyn®) Use in the Inpatient Setting | 08.00.49f | | 3/11/2024 | | | 3/11/2024 | Medical Necessity Criteria | | |
| Updated Policies | Lanreotide (Somatuline® Depot) | 08.01.40f | | 3/11/2024 | | | 3/11/2024 | Medical Necessity Criteria | | |
| Updated Policies | Omalizumab (Xolair®) | 08.00.55j | | 3/11/2024 | | | 3/11/2024 | Medical Necessity Criteria;Medical Coding;General Description, Guidelines, or Informational Update | | |
| Updated Policies | Cardiac Rehabilitation (CR) and Intensive Cardiac Rehabilitation (ICR) Programs | 10.01.01r | | 3/11/2024 | | | 3/11/2024 | General Description, Guidelines, or Informational Update | | |
| Updated Policies | Ado-Trastuzumab Emtansine (Kadcyla®) | 08.01.11i | | 3/11/2024 | | | 3/11/2024 | Medical Necessity Criteria;Medical Coding | | |
| Updated Policies | Dostarlimab-gxly (Jemperli) | 08.01.79e | | 3/11/2024 | | | 3/11/2024 | Medical Necessity Criteria | | |
| Updated Policies | Subcutaneous Implantable Cardioverter Defibrillator (S-ICD) for Treating Life-threatening Ventricular Tachyarrhythmia | 05.00.77e | | 3/25/2024 | | | 3/25/2024 | Medical Coding;General Description, Guidelines, or Informational Update | | |
| Reissue Policies | Non-Surgical Spinal Decompression Therapy | 07.08.01f | | 3/28/2016 | 3/6/2024 | | 3/6/2024 | | | |
| Reissue Policies | Allogeneic Processed Thymus Tissue-agdc (Rethymic®) | 08.01.88 | | 5/16/2022 | 3/6/2024 | | 3/6/2024 | | | |
| Reissue Policies | Frenectomy, Frenotomy, or Frenoplasty for Ankyloglossia (Tongue-Tie) | 11.03.05e | | 1/1/2021 | 3/6/2024 | | 3/6/2024 | | | |
| Reissue Policies | Computer-assisted Musculoskeletal Surgical Navigational Orthopedic Procedure | 11.14.17e | | 1/1/2021 | 3/6/2024 | | 3/6/2024 | | | |
| Reissue Policies | Ambulatory Blood Pressure Monitoring (ABPM) and Home Blood Pressure Monitoring (HBPM) Devices | 07.02.09i | | 10/1/2023 | 3/6/2024 | | 3/6/2024 | | | |
| Reissue Policies | Percutaneous Discectomy | 11.15.15g | | 12/1/2017 | 3/6/2024 | | 3/6/2024 | | | |
| Reissue Policies | Brachytherapy and Accelerated Whole Breast Irradiation using Three-Dimensional Conformation Radiation Therapy | 09.00.10z | | 7/15/2019 | 3/6/2024 | | 3/6/2024 | | | |
| Reissue Policies | Routine Foot Care for Certain Medical Conditions | 07.07.01q | | 10/1/2021 | 3/6/2024 | | 3/6/2024 | | | |
| Reissue Policies | Mohs Micrographic Surgery | 11.08.23k | | 10/1/2023 | 3/6/2024 | | 3/6/2024 | | | |
| Reissue Policies | Elective Abortion | 11.06.02l | | 1/2/2024 | 3/6/2024 | | 3/6/2024 | | | |
| Reissue Policies | Gastric Electrical Stimulation (Enterra™), Gastric Pacing | 11.03.15k | | 1/2/2024 | 3/20/2024 | | 3/20/2024 | | | |
| Reissue Policies | Endometrial Ablation | 11.06.05f | | 5/20/2019 | 3/20/2024 | | 3/20/2024 | | | |
| Reissue Policies | Fetal Fibronectin Enzyme (fFN) Immunoassay | 06.02.04d | | 12/4/2015 | 3/20/2024 | | 3/20/2024 | | | |
| Reissue Policies | Serodiagnosis of Inflammatory Bowel Disease (IBD) and the Prometheus® IBD sgi Diagnostic™ Test | 06.02.17h | | 4/1/2020 | 3/20/2024 | | 3/20/2024 | | | |
| Reissue Policies | Uterine Artery Embolization | 11.06.04k | | 5/20/2019 | 3/20/2024 | | 3/20/2024 | | | |
| Reissue Policies | Parenterally Administered Terbutaline Sulfate for the Prevention or Treatment of Pre-Term Labor | 07.10.04c | | 2/22/2017 | 3/20/2024 | | 3/20/2024 | | | |
| Reissue Policies | Manipulation Under Anesthesia | 11.14.24b | | 4/30/2018 | 3/20/2024 | | 3/20/2024 | | | |
| Archived Policies | Partial Coherence Interferometry | 07.13.08e | 3/8/2024 1:00 PM | 4/8/2024 | | | 3/8/2024 | | | |
